Болевой синдром и когнитивные функции – борьба за когнитивный резерв

Боль в спине и головная боль являются наиболее частыми болевыми синдромами и оказывают значимое влияние на качество жизни пациентов. В процессе хронизации боли выделяют эмоционально-аффективный, когнитивный и мотивационный компоненты. Когнитивные нарушения (КН), такие как дефицит внимания, снижение памяти, снижение способности к обучению и принятию решений, наблюдаются почти у трети пациентов с хронической болью. При этом спектр КН у пациентов с хронической болью в спине зависит от возраста. Первичная головная боль также ассоциирована с развитием КН. Важной мерой профилактики КН при хронической боли является эффективное купирование болевого синдрома. Лорноксикам – нестероидный противовоспалительный препарат, который работает на разных уровнях формирования боли. Обсуждаются взаимное влияние боли в спине и головной боли на когнитивные функции, а также поддержание когнитивного потенциала при комплексном лечении пациентов.

1. Cimmino MA, Ferrone C, Cutolo M. Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol. 2011 Apr;25(2):173-83. doi: 10.1016/j.berh.2010.01.012

2. Higgins DM, Martin AM, Baker DG, et al. The Relationship Between Chronic Pain and Neurocognitive Function: A Systematic Review. Clin J Pain. 2018 Mar;34(3):262-75. doi: 10.1097/AJP.0000000000000536

3. Vancleef LM, Peters ML. Pain catastrophizing, but not injury/illness sensitivity or anxiety sensitivity, enhances attentional interference by pain. J Pain. 2006 Jan;7(1):23-30. doi: 10.1016/j.jpain.2005.04.003

4. Moriarty O, McGuire BE, Finn DP. The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol. 2011 Mar;93(3):385-404. doi: 10.1016/j.pneurobio.2011.01.002. Epub 2011 Jan 7.

5. Oosterman JM, Derksen LC, van Wijck AJ, et al. Memory functions in chronic pain: examining contributions of attention and age to test performance. Clin J Pain. 2011 Jan;27(1):70-5. doi: 10.1097/AJP.0b013e3181f15cf5

6. Berryman C, Stanton TR, Jane Bowering K, et al. Evidence for working memory deficits in chronic pain: a systematic review and metaanalysis. Pain. 2013 Aug;154(8):1181-96. doi: 10.1016/j.pain.2013.03.002. Epub 2013 Mar 14.

7. Todd J, Sharpe L, Johnson A, et al. Towards a new model of attentional biases in the development, maintenance, and management of pain. Pain. 2015 Sep;156(9):1589-600. doi: 10.1097/j.pain.0000000000000214

8. Sepe C, Colao AM, Merola B, et al. Headache and memory impairment. Study on 100 headache patients. Acta Neurol (Napoli). 1993 Dec;15(6):421-6.

9. Kuhajda MC, Thorn BE, Klinger MR, Rubin NJ. The effect of headache pain on attention (encoding) and memory (recognition). Pain. 2002 Jun;97(3):213-21. doi: 10.1016/S0304-3959(01)00488-2

10. Moore DJ, Keogh E, Eccleston C. The interruptive effect of pain on attention. Q J Exp Psychol (Hove). 2012;65(3):565-86. doi: 10.1080/17470218.2011.626865. Epub 2011 Dec 5.

11. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Aug 22;386(9995):743-800. doi: 10.1016/S0140-6736(15)60692-4. Epub 2015 Jun 7.

12. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1789-858. doi: 10.1016/S0140- 6736(18)32279-7. Epub 2018 Nov 8. Erratum in: Lancet. 2019 Jun 22;393(10190):e44. doi: 10.1016/S0140-6736(19)31047-5

13. Парфенов ВА, Парфенова ЕВ. Персонализированный подход к ведению пациентов с хронической неспецифической болью в спине. Медицинский совет. 2022;16(11):48- 53. doi: 10.21518/2079-701X-2022-16-11-48-53

14. Парфенов ВА, Головачева ВА, Исайкин АИ и др. Лечение хронической неспецифической (скелетно-мышечной) боли в спине. Неврология, нейропсихиатрия, психосоматика. 2024;16(3S):1-16. doi: 10.14412/2074-2711-2024-3S-1-16

15. Linton SJ, Hallden K. Can we screen for problematic back pain? A screening questionnaire for predicting outcome in acute and subacute back pain. Clin J Pain. 1998 Sep;14(3):209-15. doi: 10.1097/00002508-199809000-00007

16. Петелин ДС, Истомина НС, Цапко ДС и др. Подходы к психотерапии хронической скелетно-мышечной боли. Неврология, нейропсихиатрия, психосоматика. 2022;14(3):68- 73. doi: 10.14412/2074-2711-2022-3-68-73

17. Gulpers B, Ramakers I, Hamel R, et al. Anxiety as a Predictor for Cognitive Decline and Dementia: A Systematic Review and MetaAnalysis. Am J Geriatr Psychiatry. 2016 Oct;24(10):823-42. doi: 10.1016/j.jagp.2016.05.015. Epub 2016 Jul 4.

18. Lipnicki DM, Makkar SR, Crawford JD, et al; for Cohort Studies of Memory in an International Consortium (COSMIC). Determinants of cognitive performance and decline in 20 diverse ethno-regional groups: A COSMIC collaboration cohort study. PLoS Med. 2019 Jul 23;16(7):e1002853. doi: 10.1371/journal.pmed.1002853

19. Santabarbara J, Lipnicki DM, Bueno-Notivol J, et al. Updating the evidence for an association between anxiety and risk of Alzheimer's disease: A meta-analysis of prospective cohort studies. J Affect Disord. 2020 Feb 1;262:397-404. doi: 10.1016/j.jad.2019.11.065. Epub 2019 Nov 11.

20. Lindert J, Paul KC, Lachman ME, et al. Depression-, Anxiety-, and Anger and Cognitive Functions: Findings From a Longitudinal Prospective Study. Front Psychiatry. 2021 Aug 6;12:665742. doi: 10.3389/fpsyt.2021.665742

21. Мелкумова КА, Подчуфарова EB, Яхно НН. Особенности когнитивных функций у пациентов, страдающих хроническими болями в спине. Боль. 2009;(3):64-5.

22. Yang S, Chang MC. Chronic Pain: Structural and Functional Changes in Brain Structures and Associated Negative Affective States. Int J Mol Sci. 2019 Jun 26;20(13):3130. doi: 10.3390/ijms20133130

23. Ouanes S, Popp J. High Cortisol and the Risk of Dementia and Alzheimer's Disease: A Review of the Literature. Front Aging Neurosci. 2019 Mar 1;11:43. doi: 10.3389/fnagi.2019.00043

24. Kelkar RA, Kaye AD, Perilloux DM, et al. Evolving role of immunology in chronic pain medicine: tissue necrosis factor and interleukin modulatory treatments. Explor Immunol. 2024;4:523-32. doi: 10.37349/ei.2024.00156

25. Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020 Nov 26;9(1):42. doi: 10.1186/s40035-020-00221-2

26. Launer LJ. Nonsteroidal anti-inflammatory drugs and Alzheimer disease: what's next? JAMA. 2003 Jun 4;289(21):2865-7. doi: 10.1001/jama.289.21.2865. Erratum in: JAMA. 2003 Sep 3;290(9):1154.

27. Van Steenbergen H, Eikemo M, Leknes S. The role of the opioid system in decision making and cognitive control: A review. Cogn Affect Behav Neurosci. 2019 Jun;19(3):435-58. doi: 10.3758/s13415-019-00710-6

28. Gil-Gouveia R, Oliveira AG, Martins IP. The impact of cognitive symptoms on migraine attack-related disability. Cephalalgia. 2016 Apr;36(5):422-30. doi: 10.1177/0333102415604471. Epub 2015 Sep 8.

29. Gil-Gouveia R, Martins IP. Clinical description of attack-related cognitive symptoms in migraine: A systematic review. Cephalalgia. 2018 Jun;38(7):1335-50. doi: 10.1177/0333102417728250. Epub 2017 Aug 28.

30. Quintela E, Castillo J, Munoz P, Pascual J. Premonitory and resolution symptoms in migraine: a prospective study in 100 unselected patients. Cephalalgia. 2006 Sep;26(9):1051- 60. doi: 10.1111/j.1468-2982.2006.01157.x

31. Gil-Gouveia R, Oliveira AG, Martins IP. Subjective Cognitive Symptoms During a Migraine Attack: A Prospective Study of a Clinic-Based Sample. Pain Physician. 2016 Jan;19(1):E137-50.

32. Tolner EA, Chen SP, Eikermann-Haerter K. Current understanding of cortical structure and function in migraine. Cephalalgia. 2019 Nov;39(13):1683-99. doi: 10.1177/0333102419840643. Epub 2019 Mar 28.

33. Afridi SK, Giffin NJ, Kaube H, et al. A positron emission tomographic study in spontaneous migraine. Arch Neurol. 2005 Aug;62(8):1270-5. doi: 10.1001/archneur.62.8.1270

34. Vuralli D, Boran HE, Cengiz B, et al. Somatosensory temporal discrimination remains intact in tension-type headache whereas it is disrupted in migraine attacks. Cephalalgia. 2017 Nov;37(13):1241-7. doi: 10.1177/0333102416677050. Epub 2016 Nov 4.

35. Schulte LH, May A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016 Jul;139(Pt 7):1987-93. doi: 10.1093/brain/aww097. Epub 2016 May 5.

36. Aurora SK, Brin MF. Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies. Headache. 2017 Jan;57(1):109-25. doi: 10.1111/head.12999. Epub 2016 Dec 2.

37. Schwedt TJ, Chong CD, Wu T, et al. Accurate Classification of Chronic Migraine via Brain Magnetic Resonance Imaging. Headache. 2015 Jun;55(6):762-77. doi: 10.1111/head.12584

38. Gil-Gouveia R, Oliveira AG, Martins IP. A subjective cognitive impairment scale for migraine attacks. The MIG-SCOG: development and validation. Cephalalgia. 2011 Jul;31(9):984-91. doi: 10.1177/0333102411408359. Epub 2011 May 31.

39. Smith AP. Acute Tension-Type Headaches Are Associated with Impaired Cognitive Function and More Negative Mood. Front Neurol. 2016 Mar 29;7:42. doi: 10.3389/fneur.2016.00042

40. Yang FC, Lin TY, Chen HJ, et al. Increased Risk of Dementia in Patients with Tension-Type Headache: A Nationwide Retrospective Population-Based Cohort Study. PLoS One. 2016 Jun 7;11(6):e0156097. doi: 10.1371/journal.pone.0156097

41. Hagen K, Stordal E, Linde M, et al. Headache as a risk factor for dementia: a prospective population-based study. Cephalalgia. 2014 Apr;34(5):327-35. doi: 10.1177/0333102413513181. Epub 2013 Nov 21.

42. Straete Rottereng AK, Bosnes O, Stordal E, et al. Headache as a predictor for dementia: The HUNT Study. J Headache Pain. 2015;16:89. doi: 10.1186/s10194-015-0573-x. Epub 2015 Oct 15.

43. Chuang CS, Lin CL, Lin MC, et al. Migraine and risk of dementia: a nationwide retrospective cohort study. Neuroepidemiology. 2013;41(3-4):139-45. doi: 10.1159/000353559. Epub 2013 Jul 30.

44. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005 Aug;9(4):463-84. doi: 10.1016/j.ejpain.2004.11.001. Epub 2005 Jan 21.

45. Svoboda E, McKinnon MC, Levine B. The functional neuroanatomy of autobiographical memory: a meta-analysis. Neuropsychologia. 2006;44(12):2189-208. doi: 10.1016/j.neuropsychologia.2006.05.023. Epub 2006 Jun 27.

46. Schmidt-Wilcke T, Leinisch E, Straube A, et al. Gray matter decrease in patients with chronic tension type headache. Neurology. 2005 Nov 8;65(9):1483-6. doi: 10.1212/01.wnl.0000183067.94400.80

47. Van Straaten EC, Harvey D, Scheltens P, et al; Alzheimer's Disease Cooperative Study Group. Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. J Neurol. 2008 Sep;255(9):1302-8. doi: 10.1007/s00415-008-0874-y. Epub 2008 Sep 25.

48. Gorelick PB. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann N Y Acad Sci. 2010 Oct;1207:155-62. doi: 10.1111/j.1749-6632.2010.05726.x

49. Toriello M, Gonzalez-Quintanilla V, Perez-Pereda S, et al. The Potential Role of the Glymphatic System in Headache Disorders. Pain Med. 2021 Dec 11;22(12):3098-100. doi: 10.1093/pm/pnab137

50. Mikhailov N, Virenque A, Koroleva K, et al. The role of the meningeal lymphatic system in local meningeal inflammation and trigeminal nociception. Sci Rep. 2022 May 25;12(1):8804. doi: 10.1038/s41598-022-12540-7

51. Cai Y, Zhang Y, Leng S, et al. The relationship between inflammation, impaired glymphatic system, and neurodegenerative disorders: A vicious cycle. Neurobiol Dis. 2024 Mar;192:106426. doi: 10.1016/j.nbd.2024.106426. Epub 2024 Feb 7.

52. Seminowicz DA, Davis KD. Interactions of pain intensity and cognitive load: the brain stays on task. Cereb Cortex. 2007 Jun;17(6):1412-22. doi: 10.1093/cercor/bhl052. Epub 2006 Aug 14.

53. Kamper SJ, Apeldoorn AT, Chiarotto A, et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain. Cochrane Database Syst Rev. 2014 Sep 2;2014(9):CD000963. doi: 10.1002/14651858.CD000963.pub3

54. Chowdhury AR, Graham PL, Schofield D, et al. Cost-effectiveness of Multidisciplinary Interventions for Chronic Low Back Pain: A Narrative Review. Clin J Pain. 2021 Nov 22;38(3):197-207. doi: 10.1097/AJP.0000000000001009

55. McGeer PL, McGeer E, Rogers J, Sibley J. Anti-inflammatory drugs and Alzheimer disease. Lancet. 1990 Apr 28;335(8696):1037. doi: 10.1016/0140-6736(90)91101-f

56. Cuello AC. Early and Late CNS Inflammation in Alzheimer's Disease: Two Extremes of a Continuum? Trends Pharmacol Sci. 2017 Nov;38(11):956-66. doi: 10.1016/j.tips.2017.07.005. Epub 2017 Aug 31.

57. Avramovich Y, Amit T, Youdim MB. Nonsteroidal anti-inflammatory drugs stimulate secretion of non-amyloidogenic precursor protein. J Biol Chem. 2002 Aug 30;277(35):31466- 73. doi: 10.1074/jbc.M201308200. Epub 2002 Jun 17.

58. Gorsky VA, Agapov MA, Khoreva MV, Leonenko IV. The effect of lornoxicam on TLR2 and TLR4 messenger RNA expression and tumor necrosis factor-α, interleukin-6, and interleukin-8 secretion in patients with systemic complications of acute pancreatitis. Pancreas. 2015 Jul;44(5):824-30. doi: 10.1097/MPA.0000000000000344

59. Tsakiridis K, Zarogoulidis P, Vretzkakis G, et al. Effect of lornoxicam in lung inflammatory response syndrome after operations for cardiac surgery with cardiopulmonary bypass. J Thorac Dis. 2014 Mar;6 Suppl 1(Suppl 1):S7-S20. doi: 10.3978/j.issn.2072-1439.2013.12.30

60. Общая характеристика лекарственного препарата (ОХЛП) Ксефокам, таблетки, ЛП-№(006807)-(РГ-RU) от 09.09.2024.

61. Инструкция по медицинскому применению препарата Ксефокам Рапид ЛС-000323 от 05.05.2010.

62. Hillstrom C, Jakobsson JG. Lornoxicam: pharmacology and usefulness to treat acute postoperative and musculoskeletal pain a narrative review. Expert Opin Pharmacother. 2013 Aug;14(12):1679-94. doi: 10.1517/14656566.2013.805745. Epub 2013 May 29.

63. Swarnamba UN, Veena K, Shaikh SI. Comparison of the efficacy of lornoxicam and fentanyl in attenuating the hemodynamic response to laryngoscopy and intubation. Anesth Essays Res. 2016 Sep-Dec;10(3):478-82. doi: 10.4103/0259-1162.177521

64. Lorenz IH, Egger K, Schubert H, et al. Lornoxicam characteristically modulates cerebral pain-processing in human volunteers: a functional magnetic resonance imaging study. Br J Anaesth. 2008 Jun;100(6):827-33. doi: 10.1093/bja/aen082. Epub 2008 Apr 21.

65. Общая характеристика лекарственного препарата (ОХЛП) Ксефокам, лиофилизат ЛП-№(005000)-(РГ-RU) от 09.09.2024.

66. Radhofer-Welte S, Dittrich P, Simin M, Branebjerg PE. Comparative bioavailability of lornoxicam as single doses of quick-release tablet, standard tablet and intramuscular injection: a randomized, open-label, crossover phase I study in healthy volunteers. Clin Drug Investig. 2008;28(6):345-51. doi: 10.2165/00044011-200828060-00002

67. Головачева ВА, Головачева АА, Фатеева ТГ. Клинические принципы диагностики и лечения скелетно-мышечной (неспецифической) боли в нижней части спины. Неврология, нейропсихиатрия, психосоматика. 2021;13(3):107-12. doi: 10.14412/2074-2711-2021-3-107-112

68. Парфенов ВА, Яхно НН, Кукушкин МЛ и др. Острая неспецифическая (скелетномышечная) поясничная боль. Рекомендации Российского общества по изучению боли (РОИБ). Неврология, нейропсихиатрия, психосоматикa. 2018;10(2):4-11. doi: 10.14412/2074-2711-2018-2-4-11

69. Stochkendahl MJ, Kjaer P, Hartvigsen J, et al. National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy. Eur Spine J. 2018 Jan;27(1):60-75. doi: 10.1007/s00586-017-5099-2. Epub 2017 Apr 20.